We feel it’s important to maintain a high level of thought leadership in our field, providing insight and guidance to the health science domain in order to better serve the interests of our customers and, ultimately, patients.
This whitepaper covers the concept of data federation within a trusted research environment by using the example of Aridhia’s work with the PHEMS consortium.
Oncology candidates fail at twice the rate of other therapeutic areas. This paper examines root causes of attrition from first-in-human through to registration.
DOI: 10.1002/cpdd.1464
How AI guides precision dosing, therapeutic drug monitoring, biomarker integration and individualised pharmacotherapy. Published J Pediatr Pharmacol Ther, 2024.
DOI: 10.5863/1551-6776-29.4.434
C-Path and partners report progress on an FDA-funded MIDD e-learning curriculum for regulatory scientists — published in Clinical Pharmacology & Therapeutics.
DOI: 10.1002/cpt.3039
How the Liver Cancer Collaborative implemented precision medicine using the Aridhia DRE. A blueprint for governed, collaborative cancer research delivery.
DOI: 10.1016/j.ijmedinf.2024.105708
How DRE connectivity enables platform trials. Shared infrastructure, governed multi-site data access, and adaptive trial design at scale.
DOI: 10.1016/j.cct.2024.107559
This paper scores the DRE against the four sections of the SATRE specification and summarises some of the features that we believe contribute toward that score.
